Picture of Xvivo Perfusion AB logo

XVIVO Xvivo Perfusion AB Share Price

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapHigh Flyer

Momentum

Relative Strength (%)
1m-0.56%
3m-18.16%
6m-11.16%
1yr-2.76%
Volume Change (%)
10d/3m-22.66%
Price vs... (%)
52w High-18.92%
50d MA-1.95%
200d MA-1.65%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)92.53
PEG Ratio (f)n/a
EPS Growth (f)-22.14%
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value4.51
Price to Tang. Book12.11
Price to Free Cashflow189.52
Price to Sales14.68
EV to EBITDA128.83

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital0.2%
Return on Equity5.44%
Operating Margin0.7%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total RevenueSEKm220.84179.86258.39415.29597.54804.561,09526.04%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%-61.37n/an/a+201.33+406.98-46.04+128.33n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Xvivo Perfusion AB EPS forecast chart

Profile Summary

Xvivo Perfusion AB is a Sweden-based medical technology company focused on developing optimized solutions for organ, tissue and cell preservation in connection with transplantation. The Company operates in two segments: Durable goods and Non-Durable goods. The Durable goods segment comprises sale and rental income from XVIVO Perfusion System (XPS) machines. The Non-Durable goods segment implies revenue from the sale of products and services that are solutions and disposable items. The Company’s product portfolio consists of Perfadex, STEEN Solution, XPS, XPS Disposable Kit, XVIVO Lung Cannula Set, XVIVO Organ Chamber, XPS PGM Disposable Sensors and Silicone Tubing Set. The Company markets its products in Europe, Asia, Middle East, and North & South America.

Directors

Last Annual
December 31st, 2023
Last Interim
December 31st, 2023
Incorporated
December 17th, 1998
Public Since
October 8th, 2012
No. of Employees
144
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
se flag iconOMX Nordic Exchange Stockholm
Shares in Issue
31,499,470

XVIVO Share Price Performance

Upcoming Events for XVIVO

Q1 2024 Xvivo Perfusion AB Earnings Release

Q1 2024 Xvivo Perfusion AB Earnings Call

Xvivo Perfusion AB Annual Shareholders Meeting

Q2 2024 Xvivo Perfusion AB Earnings Release

Q2 2024 Xvivo Perfusion AB Earnings Call

Similar to XVIVO

Picture of Acarix AB logo

Acarix AB

se flag iconOMX Nordic Exchange Stockholm

Picture of ADDvise AB (publ) logo

ADDvise AB (publ)

se flag iconOMX Nordic Exchange Stockholm

Picture of ADDvise AB (publ) logo

ADDvise AB (publ)

se flag iconOMX Nordic Exchange Stockholm

Picture of Aegirbio AB logo

Aegirbio AB

se flag iconOMX Nordic Exchange Stockholm

Picture of Arcoma AB logo

Arcoma AB

se flag iconOMX Nordic Exchange Stockholm

FAQ